title: SOX1 antibodies in Lambert-Eaton myasthenic syndrome and screening for small cell lung carcinoma.
abstract: Lambert-Eaton myasthenic syndrome (LEMS) is an autoimmune disorder of the neuromuscular synapse. About half of LEMS patients have an associated small cell lung carcinoma (SCLC), which is usually detected after diagnosis of LEMS. This short review summarizes clinical and serological markers shown to predict the presence of SCLC in LEMS patients. SOX1 antibodies are a specific marker for SCLC-LEMS but they are also found in SCLC patients without paraneoplastic neurological syndromes. No relation to any clinical characteristic or survival effect has been found for SOX1-positive patients. Several clinical markers also discriminate between SCLC-LEMS and nontumor LEMS. Detailed analysis of these clinical and demographic characteristics from two independent patient cohorts has led to development of the DELTA-P score. This prediction model has provided for a simple clinical tool to indicate the presence of SCLC early in the course of the disease. The DELTA-P score can be used to guide tumor screening in individual patients.
authors.affiliation: Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands.
authors.forename: Alexander F
authors.initials: AF
authors.lastname: Lipka
authors.forename: Jan J G M
authors.initials: JJ
authors.lastname: Verschuuren
authors.forename: Maarten J
authors.initials: MJ
authors.lastname: Titulaer
mesh_terms: D000906:Antibodies / Q000276:immunology*; D014408:Biomarkers, Tumor / Q000032:analysis; D018288:Carcinoma, Small Cell / Q000175:diagnosis* / Q000276:immunology / Q000503:physiopathology; D006801:Humans; D015624:Lambert-Eaton Myasthenic Syndrome / Q000276:immunology* / Q000503:physiopathology; D008175:Lung Neoplasms / Q000175:diagnosis* / Q000276:immunology / Q000503:physiopathology; D055748:SOXB1 Transcription Factors / Q000276:immunology*
chemical_list: D000906:Antibodies; D014408:Biomarkers, Tumor; C490906:SOX1 protein, human; D055748:SOXB1 Transcription Factors